Oslo Dialysis in Vero Beach, Florida - Dialysis Center

Oslo Dialysis is a medicare approved dialysis facility center in Vero Beach, Florida and it has 11 dialysis stations. It is located in Indian River county at 100 S Us Highway 1, Vero Beach, FL, 32962. You can reach out to the office of Oslo Dialysis at (772) 567-8496. This dialysis clinic is managed and/or owned by Davita. Oslo Dialysis has the following ownership type - Profit. It was first certified by medicare in January, 2017. The medicare id for this facility is 682615 and it accepts patients under medicare ESRD program.

Name	Oslo Dialysis
Location	100 S Us Highway 1, Vero Beach, Florida
No. of Dialysis Stations	11
Medicare ID	682615
Managed By	Davita
Ownership Type	Profit
Late Shifts	No

Dialysis Facilities may have multiple NPI numbers. We have found possible NPI number/s associated with Oslo Dialysis from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number	1821447962
Organization Name	Oslo Dialysis
Doing Business As	Bonister Dialysis, Llc
Address	100 S Us Highway 1 Vero Beach, Florida, 32962
Phone Number	(615) 320-4214

Dialysis patients with Hemoglobin data	17
Medicare patients who had average hemoglobin (hgb) less than 10 g/dL	12

Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.

• Hemodialysis

  Adult patients getting regular hemodialysis at the center	31
  Adult patient months included in Kt/V greater than or equal to 1.2	149
  Percentage of adult patients getting regular hemodialysis at the center	86
  Percentage of pediatric patients getting regular hemodialysis at the center

An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Oslo Dialysis with elevated calcium levels.

Patients with hypercalcemia	32
Hypercalcemia patient months	150
Hypercalcemia patients with serumcalcium greater than 10.2 mg	1
Patients with Serumphosphor	36
Patients with Serumphosphor less than 3.5 mg/dL	7
Patients with Serumphosphor from 3.5 to 4.5 mg/dL	23
Patients with Serumphosphor from 4.6 to 5.5 mg/dL	23
Patients with Serumphosphor from 5.6 to 7 mg/dL	21
Patients with Serumphosphor greater than 7 mg/dL	25

The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.

Patients included in arterial venous fistula and catheter summaries	39
Patient months included in arterial venous fistula and catheter summaries	167
Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment	71
Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer	6